Pharmafile Logo

Event Logistics

Orphan drugs: the early access regulatory environment

Despite considerable variation to the rules for unlicensed orphan drugs, there are some clear first steps for a global access programme

- PMLiVE

Pan appoints new associate director and head of art

Jan Reiss joins and Rafe Burchell is promoted

- PMLiVE

Divining your future in healthcare

To soar in the face of change, leaders need the ability to engage in an ongoing process of strategic creativity

Sanofi reception

Sanofi and Regeneron’s cholesterol antibody aces phase III trial

Results confirm companies' lead over Amgen, Pfzer, Roche and Novartis

- PMLiVE

J&J files HIV combination in Europe

Seeks approval for fixed-dose tablet containing Prezista and Gilead’s cobicistat

- PMLiVE

Former FDA head to join J&J

Mark McClellan elected to pharma company’s board

- PMLiVE

Kidney cancer campaign launches in UK

The ‘Be Clear on Cancer’ campaign is aimed at raising awareness of the symptoms of bladder and kidney cancers

- PMLiVE

KnowledgePoint360 builds Scottish team

The healthcare communications specialist continues to add to the team in its new Scottish office

- PMLiVE

GCI Health’s global footprint takes another step

The WPP-owned healthcare communications agency has opened its first London office

- PMLiVE

Novo Nordisk wins US approval for haemophilia treatment

NovoEight will be launched alongside MixPro device after gaining FDA licence

INC Research appoints Dr Martin Sullivan

He joins the CRO as executive medical director for cardiovascular medicine

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links